We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
+$101M
Cap. Flow
+$158M
Cap. Flow %
1.07%
Top 10 Hldgs %
22.11%
Holding
946
New
64
Increased
332
Reduced
304
Closed
69

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$57.5M
2
AZN icon
AstraZeneca
AZN
+$44.9M
3
ADSK icon
Autodesk
ADSK
+$43.5M
4
MELI icon
Mercado Libre
MELI
+$40.7M
5
AMGN icon
Amgen
AMGN
+$33.6M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$92.5M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$88M
3
BABA icon
Alibaba
BABA
+$73.8M
4
MRK icon
Merck
MRK
+$49.8M
5
MXIM
Maxim Integrated Products
MXIM
+$48.5M

Sector Composition

Rank Sector Weight
1 Healthcare 32.09%
2 Technology 24.53%
3 Financials 9.08%
4 Communication Services 8.24%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNI icon
401
Canadian National Railway
CNI
$78.5B
$4.79M 0.03%
41,373
-565
-1% -$62.5K
RMD icon
402
ResMed
RMD
$31.1B
$4.79M 0.03%
18,176
-731
-4% -$200K
CDW icon
403
CDW
CDW
$18.9B
$4.75M 0.03%
26,090
+3,384
+15% +$639K
AEO icon
404
American Eagle Outfitters
AEO
$2.94B
$4.71M 0.03%
182,777
-6,483
-3% -$206K
RVTY icon
405
Revvity
RVTY
$12.6B
$4.71M 0.03%
27,153
-1,378
-5% -$243K
DOW icon
406
Dow Inc
DOW
$22B
$4.7M 0.03%
81,691
-1,609
-2% -$98.5K
EME icon
407
Emcor
EME
$29.9B
$4.63M 0.03%
40,122
+14,884
+59% +$1.78M
BLDP
408
Ballard Power Systems
BLDP
$754M
$4.58M 0.03%
326,505
+102,409
+46% +$1.62M
ACAD icon
409
Acadia Pharmaceuticals
ACAD
$4.51B
$4.58M 0.03%
275,560
– –
QSR icon
410
Restaurant Brands International
QSR
$26.2B
$4.56M 0.03%
74,389
-1,551
-2% -$99.4K
KKR icon
411
KKR & Co
KKR
$89.1B
$4.54M 0.03%
74,633
+25,859
+53% +$1.62M
GMED icon
412
Globus Medical
GMED
$11.1B
$4.52M 0.03%
59,000
+24,000
+69% +$1.93M
RARE icon
413
Ultragenyx Pharmaceutical
RARE
$2.46B
$4.46M 0.03%
49,480
– –
SPY icon
414
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$4.41M 0.03%
574,000
-58,400
-9% -$25.8M
NTRS icon
415
Northern Trust
NTRS
$21.8B
$4.4M 0.03%
40,801
-7,020
-15% -$797K
MLM icon
416
Martin Marietta Materials
MLM
$34.2B
$4.35M 0.03%
12,724
+1,511
+13% +$550K
TNDM icon
417
Tandem Diabetes Care
TNDM
$1.27B
$4.25M 0.03%
35,587
-38,000
-52% -$4.19M
MET icon
418
MetLife
MET
$62.4B
$4.24M 0.03%
68,645
-68,043
-50% -$4.1M
SONY icon
419
Sony
SONY
$137B
$4.2M 0.03%
189,935
+38,235
+25% +$801K
KMB icon
420
Kimberly-Clark
KMB
$37.6B
$4.19M 0.03%
31,651
-5,178
-14% -$704K
D icon
421
Dominion Energy
D
$62B
$4.18M 0.03%
57,300
– –
KPTI icon
422
Karyopharm Therapeutics
KPTI
$155M
$4.18M 0.03%
47,845
– –
BX icon
423
Blackstone
BX
$104B
$4.16M 0.03%
35,743
+1,743
+5% +$202K
TMUS icon
424
T-Mobile US
TMUS
$195B
$4.13M 0.03%
32,324
-827
-2% -$115K
EWC icon
425
iShares MSCI Canada ETF
EWC
$6.12B
$4.11M 0.03%
113,314
– –
15 16
17
18 19

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2021 Portfolio in Review

As of Q3 2021, Candriam SCA held 946 positions worth $14.7B, up 0.69% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA's Q3 2021 filing shows 64 new, 332 increased, 304 reduced and 69 closed positions. Its largest new stake was FIVE9: 86,075 shares worth $13.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2021 buy was FIVE9: 86,075 shares worth $13.7M.
  • Candriam SCA added most to Johnson & Johnson in Q3 2021, an estimated $57.5M increase.
  • Candriam SCA's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $88M.
  • Candriam SCA fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $92.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.7B portfolio in Q3 2021.
  • Candriam SCA opened 64 new positions and closed 69 in Q3 2021.
  • Candriam SCA's portfolio value rose 0.69% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.